- Home
- FMS vs YGMZ Comparison
FMS vs YGMZ Comparison
Compare FMS & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- YGMZ
- Stock Information
- Founded
- FMS 1996
- YGMZ 2002
- Country
- FMS Germany
- YGMZ China
- Employees
- FMS 111513
- YGMZ N/A
- Industry
- FMS Misc Health and Biotechnology Services
- YGMZ Transportation Services
- Sector
- FMS Health Care
- YGMZ Consumer Discretionary
- Exchange
- FMS Nasdaq
- YGMZ Nasdaq
- Market Cap
- FMS 13.8B
- YGMZ N/A
- IPO Year
- FMS 1996
- YGMZ 2020
- Fundamental
- Price
- FMS $24.46
- YGMZ $1.20
- Analyst Decision
- FMS Hold
- YGMZ
- Analyst Count
- FMS 1
- YGMZ 0
- Target Price
- FMS $25.00
- YGMZ N/A
- AVG Volume (30 Days)
- FMS 428.6K
- YGMZ 224.0K
- Earning Date
- FMS 05-06-2025
- YGMZ 01-01-0001
- Dividend Yield
- FMS 2.59%
- YGMZ N/A
- EPS Growth
- FMS 7.65
- YGMZ N/A
- EPS
- FMS 1.89
- YGMZ N/A
- Revenue
- FMS $20,018,541,263.00
- YGMZ $55,805,416.00
- Revenue This Year
- FMS $5.05
- YGMZ N/A
- Revenue Next Year
- FMS $3.90
- YGMZ N/A
- P/E Ratio
- FMS $25.68
- YGMZ N/A
- Revenue Growth
- FMS N/A
- YGMZ N/A
- 52 Week Low
- FMS $17.93
- YGMZ $0.64
- 52 Week High
- FMS $25.96
- YGMZ $4.35
- Technical
- Relative Strength Index (RSI)
- FMS 52.98
- YGMZ 74.02
- Support Level
- FMS $23.52
- YGMZ $0.91
- Resistance Level
- FMS $24.32
- YGMZ $1.10
- Average True Range (ATR)
- FMS 0.60
- YGMZ 0.14
- MACD
- FMS -0.00
- YGMZ 0.05
- Stochastic Oscillator
- FMS 76.51
- YGMZ 93.03
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.